U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07135310) titled 'STROKE 120 ACTION: a National Cluster Randomized Controlled Trial' on Aug. 14.
Brief Summary: Stroke is the main cause of death and disability in China, but it is preventable and treatable. For the most common type, acute ischemic stroke (AIS), initiating reperfusion therapy with intravenous thrombolysis (IVT) with or without mechanical thrombectomy (MT) within several hours of the onset of symptoms can significantly improve the chances of surviving free of major disability, and earlier the intervention is given the better the outcome. Thus, whether patients can achieve timely arrived at hospital, ideally within the critical 4.5-hou...